In this study, we attempted human tau gene knock-in at the Rosa26 locus to create a novel tauopathy mouse model that recapitulates promoter-dependent tau expression and tau pathology in the absence of endogenous gene mutations in principle, and that can be deployed for various applications. This evidence concerns the gene MAPT and tauopathy.